NEW YORK (GenomeWeb) – Horizon Discovery Group today announced a worldwide co-exclusive distribution agreement with Haplogen Genomics.

The deal provides Horizon access to a high-throughput, affordable cell line engineering service. Haplogen's experience with haploid cell lines and a highly optimized production pipeline allows knockouts for non-essential genes to be generated at hundreds of new isogenic cell lines each month, Horizon said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.